Search clinical trials for: Risperidone long-acting injection (LAI)

Total 5343 results

Shanghai Minimally Invasive Surgery Center
Wuxi Branch of Ruijin Hospital; Shanghai OneTar Biomedicine Co., Ltd.

Not yet recruiting

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

Neoadjuvant Therapy
Braeburn Pharmaceuticals

Completed

Safety and Tolerability of Risperidone Implants

Schizophrenia

United States
Braeburn Pharmaceuticals

Completed

Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Schizophrenia | Schizo-affective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.

Psychotic Disorders | Schizophrenia
Sanofi
Regeneron Pharmaceuticals

Active, not recruiting

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation (NOTUS)

Chronic Obstructive Pulmonary Disease

Greece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more
Novartis

Completed

Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Germany
Sultan Qaboos University

Completed

Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy

Retinal Dystrophies
Rovi Pharmaceuticals Laboratories

Recruiting

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse (RESHAPE)

Schizophrenia

Germany
Marion Trousselard

Terminated

Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?

Anxiety State

France
University of Geneva, Switzerland

Terminated

Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome

22q11.2 Deletion Syndrome

Switzerland
University of Alabama at Birmingham
Janssen Pharmaceuticals

Completed

Risperidone and Suicidality in Major Depressive Disorder

Depression

United States
Duke University
Janssen, LP

Terminated

Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

Schizophrenia

United States
Hoffmann-La Roche

Completed

A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone

Schizophrenia

United States
Child Psychopharmacology Institute

Completed

Actigraphic Analysis of Treatment Response

Psychomotor Agitation | Insomnia | Sleep Disorders, Circadian Rhythm

United States
Pfizer

Completed

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Schizophrenia

United States, Canada
Pfizer

Completed

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Psychotic Disorders | Schizophrenia

Russian Federation, Canada
Diakonhjemmet Hospital
Oslo University Hospital

Completed

Axillary Plexus Block in a High Resolution MRI

Magnetic Resonance Imaging | Nerve Block

Norway
Shanghai Mental Health Center

Unknown

Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime

Schizophrenia

China
Novo Nordisk A/S

Completed

Comparison of Two Formulations of Biphasic Insulin Aspart 70

Healthy | Diabetes

United Kingdom
Buchinger Wilhelmi Development & Holding GmbH
King's College London; Leiden University Medical Center; ETH Zurich; Claude Bernard... and other collaborators

Completed

Long-term Fasting: Multi-system Adaptations in Humans

Fasting

Germany
GlaxoSmithKline

Completed

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Schizophrenia

United States
Duke University
Janssen, LP

Completed

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Schizophrenia | Schizoaffective Disorder

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

Anxiety Disorders
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Bipolar Disorder | Manic Episode
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Bipolar Disorders | Manic Episode
Janssen, LP

Completed

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Schizophrenia | Schizoaffective Disorder
Central Institute of Mental Health, Mannheim

Completed

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Schizophrenia, Schizoaffective Disorder

Germany
University of Turin, Italy

Completed

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors

Neuroendocrine Tumors

Italy
Birte Glenthoj
Icahn School of Medicine at Mount Sinai

Terminated

The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia

Schizophrenia

Denmark
ValiSeek Limited

Completed

A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Adenocarcinoma | Carcinoma, Non-Small-Cell Lung
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia (PRISMA-2)

Schizophrenia

United States
Indivior Inc.

Completed

Single Ascending Dose Study of RBP-7000

Schizophrenia

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Psychotic Disorders | Schizophrenia | Emergency Treatment
Institut de Recherches Cliniques de Montreal
Novo Nordisk A/S; McMaster University

Completed

Levemir-Body Composition and Energy Metabolism

Type 2 Diabetes

Canada
Regeneron Pharmaceuticals

Completed

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection) (RE-VIEW)

Age - Related Macular Degeneration (AMD)

United States
Ophthalmic Consultants of Boston
Regeneron Pharmaceuticals

Completed

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion (ANDROID)

Central Retinal Vein Occlusion | Proliferative Diabetic Retinopathy

United States
JW Pharmaceutical

Recruiting

The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII Inhibitors

Hemophilia A With Inhibitor | Hemophilia A Without Inhibitor

Korea, Republic of
Regeneron Pharmaceuticals

Completed

Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe

Chorioretinal Vascular Disease

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone

Schizophrenia

United States
Indivior Inc.

Completed

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

Schizophrenia

United States
Janssen-Cilag Ltd.

Completed

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Schizophrenia

Brazil
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation

Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
Butler Hospital
American Foundation for Suicide Prevention

Completed

Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders (CLASP-S)

Schizophrenia | Suicide

United States
VA Office of Research and Development
Butler Hospital

Completed

Veterans Coping Long-term With Active Suicide (CLASP-VA)

Suicide

United States
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting...

Recruiting

Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT (SPACe2:STAR)

Autism Spectrum Disorder

Netherlands
Novo Nordisk A/S

Completed

A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 Diabetes (DUAL™ II)

Diabetes Mellitus, Type 2 | Diabetes

United States, India, Denmark, Hungary, Slovenia, Switzerland, Bulgaria
Indivior Inc.

Completed

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Schizophrenia

United States
US Department of Veterans Affairs

Completed

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders

Bipolar Disorder

3

Subscribe